...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Epigenetics market size

https://finance.yahoo.com/news/epigenetics-market-expected-reach-4-123000921.html

 

https://markets.businessinsider.com/news/stocks/epigenetics-market-to-reach-usd-19-12-billion-by-2026-reports-and-data-1028604293

 

 

Interesting that the entire market values  for Epigenetics has fallen from an expected   $19.12 Billon 2019 to $4.3 Billin  in 2026 and not a whisper of  a name from Zenith or Resverlogix. ....  

Still waiting for that allusive deal...

DM where's your 8 year lead ....... your management skills are as good as your academic qualifications 

 

 

 

 

Share
New Message
Please login to post a reply